Search Results - David Agapiou

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak by Charles S. P. Foster, Rowena A. Bull, Nicodemus Tedla, Fernando Santiago, David Agapiou, Anurag Adhikari, Gregory J. Walker, Lok Bahadur Shrestha, Sebastiaan J. Van Hal, Ki Wook Kim, William D. Rawlinson

    Published in Viruses (2023-02-01)
    Get full text
    Article


  2. 2

    SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays by Gregory J. Walker, Zin Naing, Alberto Ospina Stella, Malinna Yeang, Joanna Caguicla, Vidiya Ramachandran, Sonia R. Isaacs, David Agapiou, Rowena A. Bull, Sacha Stelzer-Braid, James Daly, Iain B. Gosbell, Veronica C. Hoad, David O. Irving, Joanne M. Pink, Stuart Turville, Anthony D. Kelleher, William D. Rawlinson

    Published in Viruses (2021-02-01)
    Get full text
    Article


  3. 3

    Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection by Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, Mohamed Hammoud, Chaturaka Rodrigo, Elizabeth Keoshkerian, Hui Li, Nicholas A. Brasher, Daniel Christ, Romain Rouet, Deborah Burnet, Branka Grubor-Bauk, William Rawlinson, Stuart Turville, Anupriya Aggarwal, Alberto Ospina Stella, Christina Fichter, Fabienne Brilot, Michael Mina, Jeffrey J. Post, Bernard Hudson, Nicky Gilroy, Dominic Dwyer, Sarah C. Sasson, Fiona Tea, Deepti Pilli, Anthony Kelleher, Nicodemus Tedla, Andrew R. Lloyd, Marianne Martinello, Rowena A. Bull

    Published in Cell Reports Medicine (2021-04-01)
    Get full text
    Article


Search Tools: